Koyama Hiroo, Boueres Julia K, Miller Daniel J, Berger Joel P, MacNaul Karen L, Wang Pei-ran, Ippolito Marc C, Wright Samuel D, Agrawal Arun K, Moller David E, Sahoo Soumya P
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA.
Bioorg Med Chem Lett. 2005 Jul 15;15(14):3347-51. doi: 10.1016/j.bmcl.2005.05.028.
A SAR study was conducted on chromane-2-carboxylic acid toward selective PPARalpha agonisim. As a result, highly potent, and selective PPARalpha agonists were discovered. The optimized compound 43 exhibited robust lowering of total cholesterol levels in hamster and dog animal models.
针对色满-2-羧酸进行了一项关于选择性PPARα激动作用的构效关系研究。结果发现了高效且选择性的PPARα激动剂。优化后的化合物43在仓鼠和犬动物模型中表现出显著降低总胆固醇水平的作用。